Altimmune to Participate at Two Upcoming Investor Conferences
Altimmune, Inc. (Nasdaq: ALT) will participate in two upcoming investor conferences, the JMP Life Sciences Conference in New York on May 14, 2024, and the UBS Obesity Therapeutics Day virtual conference on May 23, 2024. The company's management team will be available for 1x1 meetings and will hold Fireside Chats at specific times. The sessions will be webcast on the Altimmune website.
- None.
- None.
GAITHERSBURG, Md., May 07, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate and be available for 1x1 meetings at the following investor conferences:
- JMP Life Sciences Conference (New York, NY)
Tuesday, May 14, 2024
Fireside Chat at 9:00 a.m. Eastern Time
- UBS Obesity Therapeutics Day (Virtual Conference)
Thursday, May 23, 2024
Fireside Chat at 10:00 a.m. Eastern Time
The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.
About Altimmune
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.
Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter
Company Contact:
Richard Eisenstadt
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com
Investor Contact:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com
Julia Weilman
Burns McClellan
Phone: 646-732-4443
jweilman@burnsmc.com
Media Contact:
Danielle Cantey
Inizio Evoke Comms
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com
FAQ
When will Altimmune participate in the JMP Life Sciences Conference?
What is the date of the UBS Obesity Therapeutics Day virtual conference?
Where can the webcast of the sessions be accessed?
